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ABSTRACT Prion proteins cause neurodegenerative illnesses in humans and animals. The diseases are associated with a
topological change from a predominantly  (PrPC) to -sheet (PrPSc) structure. Many studies have focused on the minimum
sequence requirements and key events for developing or transmitting disease. Here, we report on the application of molecular
modeling studies to predict the lowest-energy conformations for five fragments in solution at pH 7. We show that PrP(143–
158) adopts a helix, the model PrP(106–126), PrP(142–167), and PrP(143–178) peptides have a clear preference for a variety
of -sheet structures, whereas PrP(127–164) has two iso-energetic conformations with all  or  native-like structures. Such
a finding for PrP(127–164), which explains a large body of experimental data, including the location of all mutations causing
prion diseases, may have important implications for triggering or propagating the topological change.
INTRODUCTION
Prion proteins are intriguing biopolymers because they can
act as infectious agents by causing self-propagating confor-
mational changes (Sparrer et al., 2000). They are also dis-
tinct from other proteins because, at present, 24 mutations
distributed throughout their sequences (see below) lead to
disorders, including Creutzfeld-Jacob disease (CJD) and
Gerstmann-Strausller-Scheinker (GSS) disease in humans,
scrapie in sheep, and bovine spongiform encephalopathy in
cows. Within the protein-only hypothesis, a detailed mech-
anism for the conformational transition is still unclear, al-
though two models have been proposed. The template-
assisted model suggests that the transition from monomeric
-helical PrPC to monomeric -rich PrPSc is the rate-limit-
ing step, followed by fast oligomerization of the subunits
(Huang et al., 1996). Alternatively, the nucleation-polymer-
ization and -nucleation models propose that molecular
association facilitates a conformational change in the mono-
mer and that aggregation of a PrPSc nucleus of critical size
is the rate-limiting step (Jarrett and Lansbury, 1993; Mor-
risey and Shakhnovich, 1999).
The physiological monomeric PrPC structure for murine
(m), Syrian hamster, and human (hu) sequences has been
characterized by NMR spectroscopy as adopting an unstruc-
tured region from residues 1 to 121 and a globular domain
with a two-stranded anti-parallel -sheet and three -helices
(Riek et al., 1996; Zahn et al., 2000). The -strands S1 and
S2 comprise residues 128–131 and 161–164, respectively.
The first helix, labeled H1, spans residues 144–153. The
helices H2 (from residues 172 to 194) and H3 (from resi-
dues 200 to 224) are bridged by a disulfide bond (Cys179–
Cys214) and make several contacts with H1, S1, and S2
(Fig. 1).
The scrapie multimeric structure, PrPSc, has not been
characterized experimentally but is known to have less
-helix and more -sheet content than PrPC. Three hypo-
thetical structural models for PrPSc have been proposed
based on immunological studies and circular dichroism
(CD) spectra. In the first model, the region between residues
90 and 145 was modeled by two consecutive -hairpins
(four strands) with strand 1 parallel to strand 3 (Huang et al.,
1996). In the second model, the secondary H1, S1, and S2
structural elements have been replaced by four adjacent
anti-parallel -strands that form a Greek key motif (Korth et
al., 1997). In the last model, PrPSc adopts -helical confor-
mations (Downing and Lazo, 1999).
The availability of truncated prion proteins has provided
new insights into the minimum sequence requirements for
prion propagation. The N-terminally truncated PrP at resi-
due 90, PrP(90–231) also termed PrP 27–30 (Prusiner,
1997), and the C-terminally truncated PrP at residue 145
(Ghetti et al., 1996) are disease causing, indicating that the
PrP(90–145) fragment is the minimal infectious unit. Re-
cent studies have also shown that PrP106, which includes
residues 89–140 and 177–230 of full-length PrP with the
intact disulfide bond, i.e., removes the region in PrPC that
form H1 and S2, also retains the ability to support PrPSc
formation in transgenic mice (Supatapone et al., 1999).
However, because PrP106 is unstructured at low concentra-
tions (Baskakov et al., 2000), PrP(90–145) is random coil in
monomeric form (Zhang et al., 1995), and the NMR solu-
tion structure of PrP(90–231) is superposable on the full
sequence structure (James et al., 1997), only the 90–231
region provides opportunities for understanding the topo-
logical change.
The aim of this study is to determine whether certain
fragments encompassing the 106–178 region have distinct
conformational properties in equilibrium at pH 7 and there-
fore could trigger the conformational change in PrPC. There
Received for publication 31 January 2001 and in final form 14 May 2001.
Address reprint requests to Dr. Philippe Derreumaux, Information Ge´ne´t-
ique et Structurale, CNRS-UMR 1889, 31 Chemin Joseph Aiguier, 13402
Marseille, France. Tel.: 33-4-91164603; Fax: 33-4-91164549; E-mail:
philippe@igs.cnrs-mrs.fr.
© 2001 by the Biophysical Society
0006-3495/01/09/1657/09 $2.00
1657Biophysical Journal Volume 81 September 2001 1657–1665
is experimental evidence that such transition occurs under
acidic conditions (Hornemann and Glockshuber, 1998). De-
spite its conformational change during conversion of PrPC
into PrPSc (Peretz et al., 1997), the region comprising res-
idues 90–105 is not taken into account because it is a highly
disordered fragment, as determined by NMR spectroscopy
(James et al., 1997). The 179–231 region is also excluded
because the disulfide bridge within the two-helix bundle is
required for PrPSc formation (Prusiner, 1997) and the PrP
structure with reduced disulfide bridge is characterized by a
major loss of -helix and increased proportion of an unor-
dered structure (Maiti and Surewicz, 2000).
Ideally, one would like to simulate the all-atom 106–178
fragment folding process by molecular dynamics simula-
tions. However, the computation time for one 1-ms trajec-
tory is not tractable yet, although recent progress has been
reported (Duan and Kollman, 1998). As an alternative, we
use a simple model of protein folding that allows extensive
sampling of conformational space. The Monte Carlo (MC)-
based approach searches the lowest-energy conformation
for the target sequence by global optimization of an effec-
tive potential (OPEP) starting from randomly chosen or
fully extended conformations (Derreumaux, 1999). Such
simulations were found to reproduce the topological fea-
tures for 31 peptides in aqueous solution, including two- and
three-helix bundles, all  (3) and mixed / (2, )
motifs (Derreumaux, 2000).
In this work, we apply the OPEP-MC approach to
predict the lowest-energy conformations for five polypep-
tides. The sequences are given in Fig. 1. The energies of
these conformations are also calculated using two indepen-
dent physical all-atom energy models (see Materials and
Methods).
The first three peptides have been extensively character-
ized by NMR and/or CD spectroscopy and thus allow direct
comparison between generated and experimental averages
in aqueous solution. Such a test is not easy because the
fragment mPrP(143–158), which in PrPC forms helix H1,
shows helical preferences (Liu et al., 1999), but mPrP(142–
167), which in PrPC forms H1 and the -strand S2, shows
strong -hairpin conformational preferences (S. Kozin and
P. Debey, in preparation), whereas the fragment hu-
PrP(106–126) samples various secondary structures when
characterized under different conditions (Salmona et al.,
1999). The latter peptide was also chosen because it exhibits
some of the pathogenic and physicochemical properties of
PrPSc (Brown et al., 1996), is cytotoxic in vivo (Ettaiche et
al., 2000), and is adjacent to the 127–164 segment.
FIGURE 1 (A) NMR structure of PrP(121–231) from mouse, PDB entry 1AG2 (Riek et al., 1996). The helices H1, H2, and H3 and the -strands S1 and
S2 are shown. (B) Sequences of the five PrP peptides, which are the subject of OPEP-MC prediction, and sequences of the five control peptides (see text).
The residues involved in the -strands S1 and S2 and in helices H1 and H2 within the NMR protein structure are underlined. Abbreviations for the amino
acids are as follows: A, Ala; C, Cys; D, Asp; E, Glu; F, Phe; G, Gly; H, His; I, Ile; K, Lys; L, Leu; M, Met; N, Asn; P, Pro; Q, Gln; R, Arg; S, Ser; V,
Val; W, Trp; Y, Tyr.
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The last two model huPrP(127–164) and huPrP(143–178)
peptides have not been studied experimentally but extend
mPrP(142–167) at both extremities and help clarify the
stability of the -hairpin structure in different environ-
ments. Furthermore, huPrP(127–164) includes H1 and the
-strands S1 and S2.
MATERIALS AND METHODS
The OPEP-MC protocol simplifies both geometry and energy representa-
tions (Derreumaux, 1999, 2000). It uses a flexible-geometry model where
each amino acid is represented by six particles, i.e., N, H, C, C, O, and
one bead with an appropriate van der Waals radius and position for the side
chains. All bond lengths, bond angles, and backbone dihedral angles , 
are free to vary except the peptide bond dihedral angles , which are fixed
at 180°. This representation reproduces experimental structures and back-
bone hydrogen bonds exactly. This is not always possible in other simpli-
fied or lattice-based schemes.
The polypeptide energy surface is modeled by a knowledge-based
potential, including solvent effects. The analytic form was obtained by
maximizing the stability gap between the energy of the native structure and
a representative ensemble of non-native structures for four training pep-
tides with 10–28 residues (Derreumaux, 1999). The final potential opti-
mizes the balance between short-range and long-range (along the se-
quence) interactions and includes weighted (w) contributions from
hydrogen bonds (EHB), bond lengths and bond angles (EL), pairwise
interactions between side chains (SCs) and -carbons (C), and finally,
-helix, -strand, and L conformational propensities for the 20 amino
acids:
E wHEHB1 wHHEHB2 wLEL wSCESC,SC
 wAEC,C  
20
wPEP  
20
wpEP  
20
wP
LEP
L (1)
The motion of the polypeptide chain is simulated with a diffusion-process-
controlled MC approach. This approach does not impose a predefined set
of conformational moves. Rather, the next conformation is generated by
diffusion-process-controlled moves, which limit the transition time from
the current conformation, is then minimized using the conjugate gradient
method, and subsequently accepted or rejected by the Metropolis criterion
based on some function of the energy change between the current and the
next conformations (Metropolis et al., 1953).
For each peptide, eight simulations were performed for 12,000 MC
steps starting from fully extended or randomly chosen compact conforma-
tions. The temperature T is set to 700 K to accelerate conformational
sampling. Three additional runs at 400 K were also carried out on
PrP(106–126) and PrP(142–167) for 20,000 MC steps. Consistency be-
tween the runs for different starting conformations and different tempera-
tures and the fact that the peptides revisit the same conformational ensem-
ble in the range 10,000–20,000 MC steps probably indicate that most
globally optimal (the lowest-energy) conformations have been located. One
simulation on hPrP(143–178) and hPrP(127–164) was also carried out at
400 K during 500 MC steps from their conformations within the protein
structure to seek their lowest-energy conformations using OPEP. These
conformations, which are the subject of energy minimization, are referred
to as NMR-minimized conformations.
Because uncertainties in the OPEP energy model cannot be totally
excluded, two independent physical all-atom potentials are also used to
estimate the energy of the final OPEP-MC-generated conformations. The
first energy model is EEF1, which combines the CHARMM19 polar
hydrogen potential energy function and a simple Gaussian model for the
solvation free energy (Lazaridis and Karplus, 1998). This potential was
found to provide a realistic picture of the effective energy surface for a
number of test proteins. The second representation is the AMBER molec-
ular mechanics function with a generalized Born solvent model, referred to
as AMBERGB (Case et al., 1999). Both potentials were used as recom-
mended by their authors (http://mingus.sci.ccny.cuny.edu/and http://www.
amber.ucsf.edu/amber/). Because the side chains of all amino acids are
represented by one bead, the all-atom models were generated using the
MaxSprout program (Holm and Sander, 1992) and the based mean-field
Confmat algorithm (Koehl and Delarue, 1994). These two sets of confor-
mations for each peptide allow one to examine the effect of different
side-chain packings on the total energy.
RESULTS
Accurate prediction for PrP(143–158),
PrP(142–167), and PrP(106–126)
As a first step toward understanding the topological change
in prion proteins, we verify that the OPEP-MC protocol
generates conformational distributions for mPrP(143–158),
mPrP(142–167), and huPrP(106–126) in agreement with
CD or NMR spectroscopy.
The NMR conformational analysis has shown that
mPrP(143–158) exists as a mixture of -helix from residues
144 to 151 (population of 40%) and random coil conforma-
tions (60%) in aqueous solution at pH 4.5, suggesting that
helix H1 could be preserved during the conformational
transition from PrPC to PrPSc (Liu et al., 1999). This se-
quence is predicted by OPEP-MC to adopt a helix from
residues 146 to 155 and a -hairpin conformation, which is
destabilized by 1.5 kBT (0.9 kcal/mol) relative to the helical
conformation. Such a marginal stability of the dominant
conformation has already been noted for other isolated
protein fragments.
In Fig. 2, we show the generated ensemble for mPrP
(142–167) in aqueous solution. All simulations converge to
the vicinity of two distinct topologies. The first fold ex-
plored contains either a regular -hairpin structure with
hydrogen-bonding interactions between the strands or a
-hairpin structure without -sheet hydrogen-bonding in-
teractions. The latter structure is more consistent with NMR
spectroscopy at pH 6.5 (S. Kozin and P. Debey, in prepa-
ration). In both structures, the turn encompasses residues
Glu152 and Tyr155. The energies of these two conforma-
tions and the NMR-minimized conformation are identical
within kBT. The second fold sampled is of  type with
residues Glu152 to Arg156 helical, and residues Trp145,
Glu146 and Tyr163, Arg164 forming a two-stranded paral-
lel -sheet. This  conformation is less stable than the
-hairpin conformations by 4 kBT and 2.5 kBT using OPEP
and EEF1 (Lazaridis and Karplus, 1998) force fields, re-
spectively. Our ensemble of conformations with extended 
and helical structures is interesting because it can reconcile
the apparent conflicting NMR data between mPrP(142–167)
at pH 6.5 and mPrP(142–170) at pH 3, where H1 remains
stable (Sharman et al., 1998). Such a large variation in NMR
results can be explained if the peptide undergoes a confor-
mational transition between pH 3 and 6.5. Although sec-
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ondary structure of huPrP(106–126) as deduced by CD
spectroscopy varies with environmental conditions,
PrP(106–126) has a high propensity to form stable -sheet
structures and to assemble into amyloid fibrils (Salmona et
al., 1999). PrP(106–126) was characterized as adopting
random coil conformation in deionized water and a mixture
of -helix (17%), -sheet (40%), and random coil (40%) in
phosphate buffer at pH 7.0 (Salmona et al., 1999). In con-
trast to the OPEP-MC simulations on PrP(143–158) and
PrP(142–167), the simulations on PrP(106–126) do not
always converge to well ordered secondary structures. Fig.
3 shows the three lowest-energy conformations, separated
by 4 kBT using OPEP. The two conformations in Fig. 3, A
and B (P1 and P2) are helical from residues 112 to 118 in P1
and 108 to 113 in P2 with random coil segments, whereas
the conformation in Fig. 3 C (P3) has three-stranded anti-
FIGURE 2 The predicted main-chain conformations for mPrP(142–
167). Bold, the native NMR structure; gray (top and middle), the lowest
energy structures; gray (bottom), the  structure.
FIGURE 3 The predicted main-chain conformations for huPrP(106–
126). The P1 (A), P2 (B), and P3 (C) conformations are shown.
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parallel -sheet structural features. The EEF1 results indi-
cate that a rather small energy difference is involved be-
tween P1 (522.9 kcal/mol) and P3 (521.0 kcal/mol), but
P2 is largely destabilized (509.0 kcal/mol). Such a con-
formational distribution, without considering entropic ef-
fects, agrees qualitatively with CD measurements.
Impact of different environments on the
144–164 region
The predicted structure ensemble for huPrP(127–164) is
shown in Fig. 4. It is interesting to note that, once the helix
H1 is partially formed in the unfolded states, the simulations
will find structures with helical properties. Three runs gen-
erate models (M1) that deviate little from the structure
within the protein (Fig. 4 A). The helix H1 is extended by
three residues, the two-stranded anti-parallel -sheet is less
regular (one hydrogen-bonding interaction between
N-Gly131 and O-Tyr162 versus two interactions from N-
Met129 to O-Tyr163 and N-Gly131 to O-Val161 within the
protein structure), but the topology is conserved. Three
other runs end up as a more distorted native structure (M2).
This structure still contains the helix H1, but the conforma-
tion of the two terminal regions has shifted from a two-
stranded anti-parallel -sheet to a parallel -sheet (Fig. 4
B). The last two runs converge to a 3 structure (M3)
consisting of two consecutive -hairpins (Fig. 4 C). The
lengths of the -strands are from Tyr128 to Arg136, Phe141
to Tyr150, and Tyr155 to Tyr163. Thus, the structure of the
region comprising residues 144–164 has slightly moved
from the NMR solution structure of mPrP(142–167). The
turn encompasses residues Tyr150 and Met154 versus
Glu152 and Tyr155 in mPrP(142–167). The energies of M1,
M2, and M3 are almost identical independently of the force
field used. They are within 6 kBT using OPEP and 13 kBT
using EEF1 (M3, 0; M2, 2; and M1, 8 kcal/mol). The
AMBERGB force field (Case et al., 1999) cannot distin-
guish M1 and M3 (0 kcal/mol) but makes the NMR-mini-
mized conformation very unstable (32 kcal/mol).
The representative predicted structure ensemble for hu-
PrP(143–178) is shown in Fig. 5. We see that the eight
simulations point to two  topologies. B1 has a four-
stranded -sheet topology with the -strand 1 anti-parallel
to the -strand 4 and the region from Ser143 to Tyr162
adopting a -hairpin structure superposable on the NMR
and predicted conformations for mPrP(142–167). B2 has a
three-stranded anti-parallel -sheet topology. The -strands
are from Tyr150 to Tyr156, Tyr162 to Tyr169, and Asn173
to Asp178, indicating a different hydrogen-bonding network in
the 142–167 region from that in B1. B1 and B2 differ by an
energy of 3 kBT using OPEP, but B2 is found less stable than
B1 by 9 and 35 kcal/mol using EEF1 and AMBERGB,
respectively. The NMR-minimized conformation is desta-
bilized by 30 kcal/mol relative to B1 using EEF1.
An important question is whether a small energy differ-
ence, E, between the M1 and M3 conformations using the
OPEP, EEF1, and AMBERGB force fields is a generic
property of the PrP(127–164) sequence. To this end, we
FIGURE 4 The predicted main-chain M1, M2, and M3 conformations
for huPrP(127–164). (A) the predicted M1 conformation (dashed line)
superposed on the full-sequence NMR solution conformation (solid line);
(B) M2; (C) M3.
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threaded five control sequences on the M1 and M3 confor-
mations. The sequences are given in Fig. 1. The first control
sequence is PrP(127–164) from chicken having 52% se-
quence identity with huPrP(127–164). The other sequences,
which are not functionally related to the prion proteins, span
residues 47–84 from Protein Information Resource entry
T41118 (26% sequence identity with PrP), residues 101–
138 from Protein Data Bank (PDB) entry 1f71, residues
30–67 from PDB entry 1lyd, and residues 40–77 from PDB
entry 1mil0. The fragments from 1f71 and 1lyd were chosen
because they exhibit -helices with 10 residues (like helix
H1) in their protein structures, whereas the fragment from
1mil0 adopts a  topology in its protein structure. The EEF1
energy difference between M1 and M3 is 6 kcal/mol for PrP
from chicken but reaches 30, 50, 40, and 22 kcal/mol for the
other sequences. These preliminary results indicate that a
small E is not an energetic property of any given sequence.
DISCUSSION
NMR spectroscopy has revealed that helix H1 in
mPrP(143–158) switches to a -hairpin in mPrP(142–167).
The simulations yield conformational ensembles consis-
tent with NMR data. The underlying question was to deter-
mine whether other fragments encompassing the 106–178
region have distinct conformational properties in equilib-
rium at pH 7.
The conclusions are based on three force fields. OPEP is
a statistical energy function optimized on short peptides,
whereas EEF1 and AMBERGB are two physics-based en-
ergy functions tested on large proteins. Because many force
fields incorrectly rank non-native conformations as being
isoenergetic or lower in free energy than native conforma-
tions, the question is whether the present conformational
distribution is not an artifact of the force field that is used.
Two factors suggest that the calculated minima do not
correspond to metastable conformations and that the degen-
eracy of the ground states for PrP(106–126) and PrP(127–
164) is physical. First, despite the dependence of the stabil-
ity of polypeptides on pH conditions (this effect is not
considered here because low pH is known to induce con-
formational conversion of the full PrP protein (Hornemann
and Glockshuber, 1998) and CD and NMR studies of two
studied fragments have been conducted at neutral pH), the
OPEP-MC simulations consistently reproduce the equilib-
rium conformations for 31 small proteins that do and do not
form ordered structures in solution. Sequences that do not
form ordered (i.e., secondary) structures include a 12-resi-
due peptide model (population of 3% of a -hairpin struc-
ture), a 17-residue-peptide from myelin basic protein, and
two isolated protein fragments, the C-helix (residues 69–
87) of myohemerythrin and the helix (12–24) of chymo-
trypsin inhibitor 2 (Derreumaux, 1999). Ordered structures
that are reproduced by OPEP-MC encompass -hairpins,
-helical hairpins, three helix bundles (Derreumaux, 1999,
2000), and more recently, more complex topologies such as
the 37-residue three-stranded anti-parallel -sheet of a pro-
totype WW domain from PDB entry 1e0m and the 56-
residue B1 domain of protein G from PDB entry 1pgb
(Derreumaux, in preparation). Second, both OPEP and
EEF1 rank the expected structures first for PrP(106–126)
and PrP(127–164). When the results are cross-validated
with the EEF1 potential, the alternate conformations that are
FIGURE 5 The predicted main-chain conformations for huPrP(143–
178) (A) B1; (B) B2.
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collected during the OPEP-MC simulations are always less
stable than the predicted conformations after energy mini-
mization. A total of 100 decoys were considered for each
protein.
Our simulations on huPrP(106–126) and huPrP(143–
178) point to  topologies. The fact that the generated
conformational ensembles include distinct  architectures is
supported by calculations using elaborated free energy func-
tions. PrP(106–126) appears to be in equilibrium between
-sheet structures and more disordered structures with he-
lical units. This result is consistent with CD conformational
analyses on PrP(106–126) (Salmona et al., 1999) and
PrP(109–141) (Zhang et al., 1995). Because PrP(106–126)
is also conformationally heterogeneous in the full PrP pro-
tein and has the propensity to make contacts with the
adjacent ordered part (James et al., 1997), we believe that
PrP(106–126) could initiate the topological change either
spontaneously or by the point mutations P102L, P105L, and
A117V. This hypothesis is supported by the recent obser-
vation that a -sheet breaker peptide spanning PrP(115–
122) partly reverses in vitro PrPSc to PrPC (Soto et al.,
2000), but alternative solutions combining also the amino
acid 129 or interactions with PrPsc (Chabry et al., 1998)
cannot be excluded. The P102L mutation can be in coupling
with methionine at PrP codon 129 (Young et al., 1995),
whereas the codon 105 mutation is strongly correlated with
codon 129 (Kitamoto et al., 1993).
On the other hand, our simulations on huPrP(127–164)
show that this fragment codes for two iso-energetic topol-
ogies either with / structural features, as found in the
NMR structure of PrP(121–231), or with -sheet structural
features. Interestingly, this  structure is characterized in
the region spanning residues from 142 to 167 by a -hairpin
very similar to that found by NMR spectroscopy for
mPrP(142–167) and by OPEP-MC for huPrP(143–178).
Taken together, these results suggest that the region from
residues 127 to 164 is likely to play a critical role in the
conformational transition to PrPSc and that the -hairpin
may be preserved in the scrapie PrPSc form. Our simula-
tions, however, cannot clarify whether a fast equilibrium
exists between the M1 and M3 states. Two simulations still
explore the starting M1 and M3 basins of attraction after
20,000 MC steps, but we cannot exclude the possibility that
escape is feasible on a longer time scale.
Our finding of two equi-energetic conformations for the
127–164 region is consistent with NMR-structure analyses,
which suggest a marginally stable 127–164 domain (James
et al., 1997) and a nucleation site within this region (Riek et
al., 1996). It is also in accord with a recent theoretical study
that underscores the propensity for helix H1 to form stable
parallel--sheet aggregates (Morrisey and Shakhnovich,
1999).
The existence of two iso-energetic conformations for
huPrP(127–164) also provides explanations for a large body
of experimental data on the full PrP protein. First, it ex-
plains why the change from neutral to acid pH conditions
shifts the two-state kinetics to three-state kinetics by stabi-
lizing a monomeric intermediate with -sheet structure in
equilibrium with the native helical state (Hornemann and
Glockshuber, 1998). Such a pH variation is certainly able to
increase the difference between the strength of contacts in
M3 and that in M1 and therefore makes the formation of the
M3 state more kinetically accessible from M1 and the
unfolded state ensemble within the protein structure. Within
this hypothesis, the 106–126 region is very likely to play an
important role, because PrP(106–126) exhibits more
-sheet content at pH 5 (61%) than at pH 7 (40%) (Salmona
et al., 1999).
Second, this conformational distribution provides a sim-
ple explanation for the position of residues contributing to
the species barrier of prion transmission between mice and
humans. These positions include residues 138, 143, 145,
155, and 166 (Riek et al., 1996). It is conceivable that the
amino acid exchanges alter the conversion time between the
M1 and M3 states in the PrPC-PrPSc complex.
Third, this model allows the formation of a -hairpin that
ensures spatial proximity of the segments 142–148, 162–
170 (see Fig. 5 A) and 214–216 of 15B3 epitope that binds
selectively to PrPSc, but not to PrPC (Korth et al., 1997). The
last two segments were also suggested to be involved in
recognition of a protein X, a hypothetical factor that might
facilitate the conversion of PrPC to PrPSc (Kaneko et al.,
1997).
Finally, this model clarifies the location of all mutations
causing prion diseases in humans (see SWISSPROT entry
P04156). The M232R and P238S mutations are not consid-
ered here because they are usually removed from PrP upon
addition of the glycosyl-phosphatidyl inositol anchor. These
residues lie within the 127–164 region. (M129V determines
the disease phenotype in patients who have a mutation at
codon 178), or they bring the 127–164 region in close
proximity to other segments in PrPC structure. The inter-
atomic contacts can be found from PDB entry 1AG2 using
the CSU program (Sobolev et al., 1999). These mutations
include A117V (contact with S1, Parchment and Essex,
2000), D178N (contact with S1, Y128 and with S2, R164),
V180I (contact with V161 through V210), T183A (contact
with V161), T188R or T188A or T188K (contact with R156
through F198), E196K (contact with R156), F198S (contact
with R156), E200K (contact with Y149), D202N (contact
with Y149 and N153), V203I (contact with Y157), R208H
(contact with I139, H140 and F141), V210I (contact with
V161), E211Q (contact with I139 through R208), and
Q217R (contact with G131).
How then could these mutations induce the formation of
PrPSc within our model? Two mechanisms can be proposed.
The first mechanism involves thermodynamic destabiliza-
tion of the native PrPC structure in isolation and thus the
native-like M1 state. Although this concept might function
for particular mutations, it is not a general mechanism
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underlying the formation of PrPSc. Indeed, the V180I
(GSS), T183A (CJD), F198S (GSS), E200K (CJD), R208H
(CJD), V210I (CJD), and Q217R (GSS) variants of
mPrP(121–231) show PrPC-like structural properties as de-
duced by CD analysis (Liemann and Glockshuber, 1999);
the NMR solution structure of the E200K variant of huPrP
superposes on the wild-type sequence structure (Zhang et
al., 2000). The second mechanism involves reduction of the
activation energy barrier between the M1 and M3 states
because of PrP-PrPSc or PrP-protein X interactions.
In summary, we have shown that both PrP(106–126) and
PrP(127–164) are prone to form scrapie-like  structures. In
contrast to PrP(106–126) and previous model peptides stud-
ied (Derreumaux, 1999, 2000), which are predicted to be in
equilibrium between their native topologies and random coil
conformations, PrP(127–164) is found to code for two dis-
tinct topologies with comparable energies in isolation. Be-
cause strand S2 interacts with helices H2 and H3, the
extrapolation of this energetic result to the behavior of the
full PrP protein in vivo remains to be validated. Neverthe-
less, this conformational distribution clarifies a large body
of experimental aspects and provides a simple explanation
for propagating and/or triggering the PrP topological
change.
I am indebted to Serguei Kozin for providing me with the NMR structure
of mPrP(142–167) and for numerous discussions. I also thank Pascale
Debey, Vincent Monchois, Yves-Henri Sanejouand, and the anonymous
referees for helpful comments.
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